Thyroid dysfunction induced by immune checkpoint inhibitors is associated with a better progression-free survival and overall survival in non-small cell lung cancer: an original cohort study
Philippe Thuillier, Claire Joly, Zarrin Alavi, Geneviève Crouzeix, R. Descourt, Gilles Quéré, V. Kerlan, Nathalie Roudaut
Topics & Concepts
MedicineNivolumabInternal medicineProgression-free survivalLung cancerProportional hazards modelCohortThyroid functionOncologyThyroidSingle CenterGastroenterologyCancerOverall survivalImmunotherapyCancer Immunotherapy and BiomarkersThyroid Cancer Diagnosis and TreatmentInflammatory Biomarkers in Disease Prognosis